Mesenchymal Stromal/Stem Cell and Minocycline-Loaded Hydrogels Inhibit the Growth of Staphylococcus aureus that Evades Immunomodulation of Blood-Derived Leukocytes

AAPS Journal

Volumn 17, Issue 3, 2015, Pages 620-630

  Guerra, Alberto Daniel ^a   Cantu, David Antonio ^a,b   Vecchi, Joseph T ^b   Rose, Warren E ^a   Hematti, Peiman ^c,d   Kao, Weiyuan John ^a,b,c,d  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b University of Wisconsin Madison   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF WISCONSIN   (United States)

Author keywords

hydrogel; leukocytes; mesenchymal stromal stem cells; minocycline; Staphylococcus aureus

Indexed keywords

HYDROGEL; MINOCYCLINE;

BIOFILM; CYTOLOGY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HUMAN; HYDROGEL; IMMUNOLOGY; IMMUNOMODULATION; LEUKOCYTE; MESENCHYMAL STROMA CELL; METABOLISM; MICROBIOLOGY; PLANKTON; STAPHYLOCOCCUS AUREUS; WOUND HEALING;

BIOFILMS; HUMANS; HYDROGELS; IMMUNOMODULATION; LEUKOCYTES; MESENCHYMAL STROMAL CELLS; MINOCYCLINE; PLANKTON; STAPHYLOCOCCUS AUREUS; WOUND HEALING;

EID: 84939935586     PISSN: None     EISSN: 15507416     Source Type: Journal    
DOI: 10.1208/s12248-015-9728-6     Document Type: Article

References (62)

1. Caplan AI. Why are MSCs therapeutic? New data: new insight. J Pathol. 2009;217(2):318–24.
2. Reitamo S, Remitz A, Tamai K, Uitto J. Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts. J Clin Invest. 1994;94(6):2489–92.
3. Jeon YK, Jang YH, Yoo DR, Kim SN, Lee SK, Nam MJ. Mesenchymal stem cells’ interaction with skin: wound-healing effect on fibroblast cells and skin tissue. Wound Repair Regen. 2010;18(6):655–61.
4. Brown JM, Nemeth K, Kushnir-Sukhov NM, Metcalfe DD, Mezey E. Bone marrow stromal cells inhibit mast cell function via a COX2-dependent mechanism. Clin Exp Allergy. 2011;41(4):526–34.
5. Renault MA, Roncalli J, Tongers J, Misener S, Thorne T, Jujo K, et al. The Hedgehog transcription factor Gli3 modulates angiogenesis. Circ Res. 2009;105(8):818–26.
6. Gruber R, Kandler B, Holzmann P, Vögele-Kadletz M, Losert U, Fischer MB, et al. Bone marrow stromal cells can provide a local environment that favors migration and formation of tubular structures of endothelial cells. Tissue Eng. 2005;11(5–6):896–903.
7. Kaigler D, Krebsbach PH, Polverini PJ, Mooney DJ. Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells. Tissue Eng. 2003;9(1):95–103.
8. Au P, Tam J, Fukumura D, Jain RK. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood. 2008;111(9):4551–8.
9. Bevan D, Gherardi E, Fan TP, Edwards D, Warn R. Diverse and potent activities of HGF/SF in skin wound repair. J Pathol. 2004;203(3):831–8.
10. Shukla MN, Rose JL, Ray R, Lathrop KL, Ray A, Ray P. Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7. Am J Respir Cell Mol Biol. 2009;40(6):643–53.
11. Fu Y, Xu K, Zheng X, Giacomin AJ, Mix AW, Kao WJ. 3D cell entrapment in crosslinked thiolated gelatin-poly (ethylene glycol) diacrylate hydrogels. Biomaterials. 2012;33(1):48–58.
12. Cantu DA, Hematti P, Kao WJ. Cell encapsulating biomaterial regulates mesenchymal stromal/stem cell differentiation and macrophage immunophenotype. Stem Cells Transl Med. 2012;1(10):740–9.
13. Wang C, Varshney RR, Wang DA. Therapeutic cell delivery and fate control in hydrogels and hydrogel hybrids. Adv Drug Deliv Rev. 2010;62(7–8):699–710.
14. Waldeck H, Kao WJ. Effect of the Addition of a Labile Gelatin Component on the Degradation and Solute Release Kinetics of a Stable PEG Hydrogel. J Biomater Sci Polym Ed. 2011.
15. Kleinbeck KR, Bader RA, Kao WJ. Concurrent in vitro release of silver sulfadiazine and bupivacaine from semi-interpenetrating networks for wound management. J Burn Care Res. 2009;30(1):98–104.
16. Fu Y, Kao WJ. Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems. Expert Opin Drug Deliv. 2010;7(4):429–44.
17. Busscher HJ, van der Mei HC, Subbiahdoss G, Jutte PC, van den Dungen JJ, Zaat SA, et al. Biomaterial-associated infection: locating the finish line in the race for the surface. Sci Transl Med. 2012;4 (153):153rv10.
18. Simoes M, Simoes LC, Vieira MJ. A review of current and emergent biofilm control strategies. Food Sci Technol. 2010;43:573–83.
19. Franz S, Rammelt S, Scharnweber D, Simon JC. Immune responses to implants—a review of the implications for the design of immunomodulatory biomaterials. Biomaterials. 2011;32(28):6692–709.
20. Arciola CR, Campoccia D, Speziale P, Montanaro L, Costerton JW. Biofilm formation in staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials. Biomaterials. 2012;33(26):5967–82.
21. Fehring TK, Odum SM, Berend KR, Jiranek WA, Parvizi J, Bozic KJ, et al. Failure of irrigation and débridement for early postoperative periprosthetic infection. Clin Orthop Relat Res. 2013;471(1):250–7.
22. Tyndall A, Pistoia V. Mesenchymal stem cells combat sepsis. Nat Med. 2009;15(1):18–20.
23. Waldeck H, Wang X, Joyce E, Kao WJ. Active leukocyte detachment and apoptosis/necrosis on PEG hydrogels and the implication in the host inflammatory response. Biomaterials. 2012;33(1):29–37.
24. Maecker HT, Trotter J. Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry A. 2006;69(9):1037–42.
25. Cohen HC, Joyce EJ, Kao WJ. Biomaterials selectively modulate interactions between human blood-derived polymorphonuclear leukocytes and monocytes. Am J Pathol. 2013;182(6):2180–90.
26. Wang X, Schmidt DR, Joyce EJ, Kao WJ. Application of MS-based proteomics to study serum protein adsorption/absorption and complement C3 activation on poly (ethylene glycol) hydrogels. J Biomater Sci Polym Ed. 2010.
27. Trivedi P, Hematti P. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp Hematol. 2008;36(3):350–9.
28. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. Int Sociol Cell Ther position statement Cyt. 2006;8(4):315–7.
29. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol. 1999;37(6):1771–6.
30. Voyich JM, Braughton KR, Sturdevant DE, Whitney AR, Saïd-Salim B, Porcella SF, et al. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol. 2005;175(6):3907–19.
31. Golic I, Velickovic K, Markelic M, Stancic A, Jankovic A, Vucetic M, et al. Calcium-induced alteration of mitochondrial morphology and mitochondrial-endoplasmic reticulum contacts in rat brown adipocytes. Eur J Histochem. 2014;58(3):2377.
32. Subbiah R, Du P, Van SY, Suhaeri M, Hwang MP, Lee K, et al. Fibronectin-tethered graphene oxide as an artificial matrix for osteogenesis. Biomed Mater. 2014;9(6):065003.
33. Pester JK, Stumpfe ST, Steinert S, Marintschev I, Plettenberg HK, Aurich M, et al. Histological, biochemical and spectroscopic changes of articular cartilage in osteoarthritis: is there a chance for spectroscopic evaluation? Z Orthop Unfall. 2014;152(5):469–79.
34. Yang M, Zhang L, Stevens J, Gibson G. CRISPR/Cas9 mediated generation of stable chondrocyte cell lines with targeted gene knockouts; analysis of an aggrecan knockout cell line. Bone. 2014;69C:118–25.
35. Li G, Yao W, Jiang H. Short-chain fatty acids enhance adipocyte differentiation in the stromal vascular fraction of porcine adipose tissue. J Nutr. 2014.
36. Aziz N, Nishanian P, Fahey JL. Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures. Clin Diagn Lab Immunol. 1998;5(6):755–61.
37. Lee SJ, Li Z, Sherman B, Foster CS. Serum levels of tumor necrosis factor-alpha and interleukin-6 in ocular cicatricial pemphigoid. Invest Optha & Vis Sci. 1993;34(13):3522–5.
38. Kleiner G, Marcuzzi A, Zanin V, Monasta L, Zauli G. Cytokine levels in the serum of healthy subjects. Mediators Inflamm. 2013;2013:434010.
39. Hoy A, Trégouët D, Leininger-Muller B, Poirier O, Maurice M, Sass C, et al. Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms. Eur J Hum Genet. 2001;9(10):780–6.
40. Chang YH, Lin IL, Tsay GJ, Yang SC, Yang TP, Ho KT, et al. Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Biochem. 2008;41(12):955–9.
41. Kobayashi SD, Braughton KR, Palazzolo-Ballance AM, Kennedy AD, Sampaio E, Kristosturyan E, et al. Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus. J Innate Immun. 2010;2(6):560–75.
42. Bantel H, Sinha B, Domschke W, Peters G, Schulze-Osthoff K, Jänicke RU. Alpha-toxin is a mediator of staphylococcus aureus-induced cell death and activates caspases via the intrinsic death pathway independently of death receptor signaling. J Cell Biol. 2001;155(4):637–48.
43. Genestier AL, Michallet MC, Prévost G, Bellot G, Chalabreysse L, Peyrol S, et al. Staphylococcus aureus Panton-valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest. 2005;115(11):3117–27.
44. Kobayashi SD, Braughton KR, Whitney AR, Voyich JM, Schwan TG, Musser JM, et al. Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc Natl Acad Sci U S A. 2003;100(19):10948–53.
45. Kobayashi SD, Voyich JM, Buhl CL, Stahl RM, DeLeo FR. Global changes in gene expression by human polymorphonuclear leukocytes during receptor-mediated phagocytosis: cell fate is regulated at the level of gene expression. Proc Natl Acad Sci U S A. 2002;99(10):6901–6.
46. Resch A, Rosenstein R, Nerz C, Götz F. Differential gene expression profiling of Staphylococcus aureus cultivated under biofilm and planktonic conditions. Appl Environ Microbiol. 2005;71(5):2663–76.
47. Leid JG, Shirtliff ME, Costerton JW, Stoodley P. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect Immun. 2002;70(11):6339–45.
48. Cowburn AS, Deighton J, Walmsley SR, Chilvers ER. The survival effect of TNF-alpha in human neutrophils is mediated via NF-kappa B-dependent IL-8 release. Eur J Immunol. 2004;34(6):1733–43.
49. Maianski NA, Roos D, Kuijpers TW. Tumor necrosis factor alpha induces a caspase-independent death pathway in human neutrophils. Blood. 2003;101(5):1987–95.
50. Raffaghello L, Bianchi G, Bertolotto M, Montecucco F, Busca A, Dallegri F, et al. Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Stem Cells. 2008;26(1):151–62.
51. El Kebir D, József L, Pan W, Filep JG. Myeloperoxidase delays neutrophil apoptosis through CD11b/CD18 integrins and prolongs inflammation. Circ Res. 2008;103(4):352–9.
52. Kolaczkowska E, Koziol A, Plytycz B, Arnold B, Opdenakker G. Altered apoptosis of inflammatory neutrophils in MMP-9-deficient mice is due to lower expression and activity of caspase-3. Immunol Lett. 2009;126(1–2):73–82.
53. Németh K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E (2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 2009;15(1):42–9.
54. Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages. Blood. 2011;118(2):330–8.
55. Mei SH, Haitsma JJ, Dos Santos CC, Deng Y, Lai PF, Slutsky AS, et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med. 2010;182(8):1047–57.
56. Schönfeld P, Siemen D, Kreutzmann P, Franz C, Wojtczak L. Interaction of the antibiotic minocycline with liver mitochondria—role of membrane permeabilization in the impairment of respiration. FEBS J. 2013;280(24):6589–99.
57. Li H, Zhang C, Liu P, Liu W, Gao Y, Sun S. In vitro interactions between fluconazole and minocycline against mixed cultures of Candida albicans and Staphylococcus aureus. J Microbiol Immunol Infect. 2014.
58. Cunha BA. Minocycline, often forgotten but preferred to trimethoprim-sulfamethoxazole or doxycycline for the treatment of community-acquired meticillin-resistant Staphylococcus aureus skin and soft-tissue infections. Int J Antimicrob Agents. 2013;42(6):497–9.
59. Cunha BA. Minocycline is a reliable and effective oral option to treat meticillin-resistant Staphylococcus aureus skin and soft-tissue infections, including doxycycline treatment failures. Int J Antimicrob Agents. 2014;43(4):386–7.
60. Fu Y, Kao WJ. Drug release kinetics and transport mechanisms from semi-interpenetrating networks of gelatin and poly (ethylene glycol) diacrylate. Pharm Res. 2009;26(9):2115–24.
61. Josef E, Barat K, Barsht I, Zilberman M, Bianco-Peled H. Composite hydrogels as a vehicle for releasing drugs with a wide range of hydrophobicities. Acta Biomater. 2013;9(11):8815–22.
62. Jordan J, Fernandez-Gomez FJ, Ramos M, Ikuta I, Aguirre N, Galindo MF. Minocycline and cytoprotection: shedding new light on a shadowy controversy. Curr Drug Deliv. 2007;4(3):225–31.